Top Stories
-
Twenty years ago, when AIDS was devastating communities in sub-Saharan Africa, Columbia's Wafaa El-Sadr created an organization to save lives in some of the continent’s hardest-hit countries.
Topic
-
Two new monoclonal antibodies are prime candidates for development into new COVID drugs for people with weak immune systems.
Topic
-
A new study published in Nature offers reassuring data on the updated COVID vaccines.
Topic
-
Quick fixes are not the answer when seeking ways to boost your immunity or increase your protection against infection.
Topic
Latest News
- January 23, 2021
Mailman experts and other policymakers discuss measures that should be deployed during vaccine rollout to reduce inequities, already worsened by the pandemic, in the U.S. and globally.
Topic
- January 15, 2021
CUIMC faculty and staff have borne witness to COVID's devastating toll and now many are sharing their own personal reasons for getting vaccinated.
Topic
- January 12, 2021
Columbia University bioethicist Maya Sabatello says a Truth and Reconciliation Commission is needed to confront the structural racism in health care (and society) highlighted by the COVID-19 pandemic.
Topic
- January 11, 2021
Cancer patients are especially vulnerable to COVID and would benefit from the protection the vaccine offers, says Gary Schwartz, MD, deputy director of the Herbert Irving Comprehensive Cancer Center.
Topic
- January 5, 2021
A strategic decision-making and team-building exercise for hospital executives—developed at Columbia University Mailman School of Public Health—now includes a simulated pandemic.
Topic
- December 31, 2020
Viral load, the amount of virus detected in a PCR nasal swab, can be used to predict patient outcomes and guide quarantine decisions, Daniel Griffin says.
Topic
- December 23, 2020
When the virus arrived in New York City, VP&S clinicians were redeployed to areas in need, researchers pivoted to COVID research, and students graduated early to help “bend the curve.”
Topic
- December 21, 2020
Front-line physicians, nurses, and staff at Columbia University Irving Medical Center have begun receiving the initial doses of the first COVID vaccines.
Topic
- December 18, 2020
A study of more than 1 million patients has found no increased risk of COVID-19 diagnosis, hospitalization, or complications for users of two common anti-hypertensive medications.
Topic
- December 2, 2020
Researchers at Columbia, UCLA, and Northeastern have begun helping the FDA in its effort to monitor the safety and effectiveness of vaccines, including COVID-19 vaccines, and other biologic products.
Topic
